Thousands of patients are at risk of losing the only medicine that works for them. Stop the removal of Cannabidiol (CBD) products from the UK market on November 1st.
Why is this important?
Whilst we welcome the move to schedule CBD as a medicine following clinical trials, it must be understood that completely removing it from the market with only 28 days notice is not sufficient time for patients to find alternative ways of maintaining their health.
CBD is well documented through clinical research to be non-toxic and non-psychoactive and has no recorded negative side effects in humans, as well as being a powerful anti-inflammatory, anti-spasmodic and anti-epilepsy drug.
This move will lead to more vulnerable patients buying untested CBD products on the illicit market, potentially bringing them to more harm or falling prey to unscrupulous cannabis oil scammers as it is an expensive product.
Thousands of patients with hundreds of medical conditions ranging from acute to life threatening rely on CBD as a safe and non-toxic form of medical and therapeutic treatment.
Patients who are buying CBD products have conditions such as Multiple Sclerosis, Parkinson's, Alzheimer’s, Crohn's Disease, Epilepsy, Fybromyalgia, Arthritis, Anxiety, Depression, Cancer, Polycystic Ovary Syndrome, Elhers Danlos Syndrome, and Chronic Pain.
We petition the MHRA to please consider other means of approving CBD products so that patients do not suffer the consequences of this decision whilst stricter regulations are decided upon.
Yours Sincerely United Kingdom Cannabis Social Clubs